Cart
sales@molnova.com
XMD-17-51 Trifluoroacetate
CAS No. 2436579-93-8
XMD-17-51 Trifluoroacetate ( XMD-17-51 Trifluoroacetate (1628614-50-5 free base) )
Catalog No. M24121 CAS No. 2436579-93-8
XMD-17-51 Trifluoroacetate is a potent and highly selective NUAK1 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 178 | In Stock |
|
| 10MG | 290 | In Stock |
|
| 25MG | 590 | In Stock |
|
| 50MG | 826 | In Stock |
|
| 100MG | 1107 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXMD-17-51 Trifluoroacetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionXMD-17-51 Trifluoroacetate is a potent and highly selective NUAK1 inhibitor.
-
DescriptionXMD-17-51 Trifluoroacetate is a potent and highly selective NUAK1 inhibitor.
-
In VitroXMD-17-51 TFA is a pyrimido-diazepinone compound that is able to modulate protein kinases, including MPS1 (TTK), ERK5 (BMK1, MAPK7), polo kinase 1, 2, 3, or 4, Ack1, Ack2, Abl, DCAMKL1, ABL1, Abl mutants, DCAMKL2, ARK5, BRK, MKNK2, FGFR4, TNK1, PLK, ULK2, PLK, PRKD1, PRKD2, PRKD3, ROS1, RPS6KA6, TAOK1, TAOK3, TNK2, Bcr-Abl, GAK, cSrc, TPR-Met, Tie2, MET, FGFR3, Aurora, Axl, Bmx, BTK, c-kit, CHK2, Flt3, MST2, p70S6K, PDGFR, PKB, PKC, Raf, ROCK-H, Rsk1, SGK, TrkA, TrkB and TrkC, and can be used in the treatment of various diseases, disorders or conditions.
-
In Vivo——
-
SynonymsXMD-17-51 Trifluoroacetate (1628614-50-5 free base)
-
PathwayMembrane Transporter/Ion Channel
-
TargetAMPK
-
RecptorNUAK1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2436579-93-8
-
Formula Weight518.49
-
Molecular FormulaC23H25F3N8O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:80 mg/ml (197.78 mM); Ethanol:8 mg/ml (19.78 mM); Water:2 mg/ml (4.94 mM)
-
SMILESO=C1N(C)C2=CN=C(NC3=CN(C4CCNCC4)N=C3)N=C2N(C)C5=CC=CC=C15.FC(C(O)=O)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Phenformin hydrochlo...
Phenformin, an anti-diabetic drug, has demonstrated antitumor activity both in vitro and in vivo.
-
ZLN-024
A novel AMPK allosteric activator that has no effect on mitochondrial function or the ADP/ATP ratio; directly activate recombinant AMPK α1β1γ1 and its homologue α2β1γ1 with EC50 of 0.42 uM and 0.95 uM, respectively.
-
ETC-1002
A small molecule regulator of lipid and carbohydrate metabolism that targets ACC (acetyl-CoA carboxylase) with IC50 of 29 uM.
